MetaVia Inc. (MTVA)

NCM – Цена в реальном времени. Валюта: USD

1.50

+0.08 (5.63%)

Рынок открыт: Aug 12, 2026, 3:13 PM EDT

1.42

+0.00 (0.04%)

Предыдущая сессия: Aug 11, 2026, 7:58 PM EDT

06.08.2026

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

All Active Patients Successfully Reached Highest Planned Dose Levels of 48 mg and 64 mg in Ongoing Phase 1 Part 3 Study of DA-1726 16-Week Topline Data Expected in the Fourth Quarter of 2026 CAMBRIDGE, Mass., Aug. 6, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate strategic update.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

MetaVia Inc. (MTVA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

MetaVia Inc. (MTVA)

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

MetaVia Inc. (MTVA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

MetaVia Inc. (MTVA)

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Видео

No Data

Пресс-релизы

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update